Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Jasper Therapeutics Inc increased its cash reserves by 125.78%, or 48.64m. Cash Flow from Financing totalled 100.97m or -- of revenues. In addition the company used 52.07m for operations while cash used for investing totalled 267.00k.
Cash flow per share | -4.87 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 6.64 |
---|---|
Tangible book value per share | 6.64 |
More ▼
Balance sheet in USDView more
Current ratio | 10.79 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼